(Q51349034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Improved glycemic control in mice lacking Sglt1 and Sglt2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

David R Powell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Christopher M DaCosta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jason Gay

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Zhi-Ming Ding

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Melinda Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jennifer Greer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Deon Doree

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sabrina Jeter-Jones

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Faika Mseeh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Lawrence A Rodriguez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Angela Harris

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Lindsey Buhring

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Kenneth A Platt

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Robert Brommage

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Melanie K Shadoan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Arthur T Sands

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Brian Zambrowicz

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

13 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

E117-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23149623%20AND%20SRC:MED&resulttype=core&format=json

Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Differences in active and passive glucose transport along the proximal nephron

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

SGLT2 inhibition--a novel strategy for diabetes treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Expression cloning and cDNA sequencing of the Na+/glucose co-transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Biochemistry of intestinal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Glucose transport by human renal Na+/D-glucose cotransporters SGLT1 and SGLT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Polymer-phloridzin conjugates as an anti-diabetic drug that inhibits glucose absorption through the Na+/glucose cotransporter (SGLT1) in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

The Sweet Pee model for Sglt2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Defects in Na+/glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Glucose sensing in L cells: a primary cell study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Carboxyl group-terminated polyamidoamine dendrimers bearing glucosides inhibit intestinal hexose transporter-mediated D-glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Long-term outcome of renal glucosuria type 0: the original patient and his natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

SGLT2 mediates glucose reabsorption in the early proximal tubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Biology of human sodium glucose transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Wnk1 kinase deficiency lowers blood pressure in mice: A gene-trap screen to identify potential targets for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Knockouts model the 100 best-selling drugs--will they model the next 100?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012

Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00439.2012